AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/101
FAMILIAL HDL DEFICIENCY CHARACTERIZED BY HYPERCATABOLISM OF MATURE APOA-I BUT NOT PROAPOA-I
Authors: BATAL R TREMBLAY M KRIMBOU L MAMER O DAVIGNON J GENEST J COHN JS
Citation: R. Batal et al., FAMILIAL HDL DEFICIENCY CHARACTERIZED BY HYPERCATABOLISM OF MATURE APOA-I BUT NOT PROAPOA-I, Arteriosclerosis, thrombosis, and vascular biology, 18(4), 1998, pp. 655-664
GENETICS OF LIPOPROTEIN DISORDERS
Authors: DAVIGNON J GENEST J
Citation: J. Davignon et J. Genest, GENETICS OF LIPOPROTEIN DISORDERS, Endocrinology and metabolism clinics of North America, 27(3), 1998, pp. 521
BEYOND LDL-CHOLESTEROL - CAN FURTHER REDUCTIONS IN CAD RISK BE ACHIEVED BY CONSIDERING TRIGLYCERIDES
Authors: DAVIGNON J PEARSON TA
Citation: J. Davignon et Ta. Pearson, BEYOND LDL-CHOLESTEROL - CAN FURTHER REDUCTIONS IN CAD RISK BE ACHIEVED BY CONSIDERING TRIGLYCERIDES, Canadian journal of cardiology, 14, 1998, pp. 2-2
ADVANCES IN DRUG-TREATMENT OF DYSLIPIDEMIA - FOCUS ON ATORVASTATIN
Authors: DAVIGNON J
Citation: J. Davignon, ADVANCES IN DRUG-TREATMENT OF DYSLIPIDEMIA - FOCUS ON ATORVASTATIN, Canadian journal of cardiology, 14, 1998, pp. 28-38
LIPOPROTEIN-LIPASE GENE-MUTATIONS IN CORONARY-ARTERY DISEASE
Authors: MINNICH A BALOUKAS J ROEDERER G LUSSIERCACAN S DAVIGNON J GENEST J
Citation: A. Minnich et al., LIPOPROTEIN-LIPASE GENE-MUTATIONS IN CORONARY-ARTERY DISEASE, Canadian journal of cardiology, 14(5), 1998, pp. 711-716
ANGIOTENSIN-CONVERTING ENZYME INSERTION DELETION POLYMORPHISM IN FRENCH-CANADIAN SUBJECTS WITH PREMATURE CORONARY-ARTERY DISEASE/
Authors: WESOLOWSKA E MARCIL M LUSSIERCACAN S DAVIGNON J LATOUR Y GENEST J
Citation: E. Wesolowska et al., ANGIOTENSIN-CONVERTING ENZYME INSERTION DELETION POLYMORPHISM IN FRENCH-CANADIAN SUBJECTS WITH PREMATURE CORONARY-ARTERY DISEASE/, Pathologie et biologie, 46(5), 1998, pp. 295-300
TREATMENT OUTCOME OF TACRINE THERAPY DEPENDS ON APOLIPOPROTEIN GENOTYPE AND GENDER OF THE SUBJECTS WITH ALZHEIMERS-DISEASE
Authors: FARLOW MR LAHIRI DK POIRIER J DAVIGNON J SCHNEIDER L HUI SL
Citation: Mr. Farlow et al., TREATMENT OUTCOME OF TACRINE THERAPY DEPENDS ON APOLIPOPROTEIN GENOTYPE AND GENDER OF THE SUBJECTS WITH ALZHEIMERS-DISEASE, Neurology, 50(3), 1998, pp. 669-677
BETA-AMYLOID PEPTIDES INCREASE THE BINDING AND INTERNALIZATION OF APOLIPOPROTEIN-E TO HIPPOCAMPAL-NEURONS
Authors: BEFFERT U AUMONT N DEA D LUSSIERCACAN S DAVIGNON J POIRIER J
Citation: U. Beffert et al., BETA-AMYLOID PEPTIDES INCREASE THE BINDING AND INTERNALIZATION OF APOLIPOPROTEIN-E TO HIPPOCAMPAL-NEURONS, Journal of neurochemistry, 70(4), 1998, pp. 1458-1466
IN-VITRO FACTORS AFFECTING THE CONCENTRATION OF GAMMA-LPE (GAMMA-LPE)IN HUMAN PLASMA
Authors: KRIMBOU L TREMBLAY M JACQUES H DAVIGNON J COHN JS
Citation: L. Krimbou et al., IN-VITRO FACTORS AFFECTING THE CONCENTRATION OF GAMMA-LPE (GAMMA-LPE)IN HUMAN PLASMA, Journal of lipid research, 39(4), 1998, pp. 861-872
PLASMA REMNANT-LIKE PARTICLE LIPID AND APOLIPOPROTEIN LEVELS IN NORMOLIPIDEMIC AND HYPERLIPIDEMIC SUBJECTS
Authors: MARCOUX C TREMBLAY M FREDENRICH A JACQUES H KRIMBOU L NAKAJIMA K DAVIGNON J COHN JS
Citation: C. Marcoux et al., PLASMA REMNANT-LIKE PARTICLE LIPID AND APOLIPOPROTEIN LEVELS IN NORMOLIPIDEMIC AND HYPERLIPIDEMIC SUBJECTS, Atherosclerosis (Amsterdam), 139(1), 1998, pp. 161-171
EXPRESSION OF GAMMA-IFN RESPONSIVE GENES IN SCAVENGER RECEPTOR OVER-EXPRESSING MONOCYTES IS ASSOCIATED WITH XANTHOMATOSIS
Authors: GREWAL T BOUDREAU M ROY M CHAMBERLAND A LEFEBVRE C LAVIGNE J DAVIGNON J MINNICH A
Citation: T. Grewal et al., EXPRESSION OF GAMMA-IFN RESPONSIVE GENES IN SCAVENGER RECEPTOR OVER-EXPRESSING MONOCYTES IS ASSOCIATED WITH XANTHOMATOSIS, Atherosclerosis (Amsterdam), 138(2), 1998, pp. 335-345
PREVALENCE OF FRENCH-CANADIAN MUTATIONS OF THE LDL-RECEPTOR AND LIPOPROTEIN-LIPASE GENES IN FAMILIES OF FAMILIAL COMBINED HYPERLIPIDEMIA
Authors: BERNIER L ROY M DUFOUR R DAVIGNON J
Citation: L. Bernier et al., PREVALENCE OF FRENCH-CANADIAN MUTATIONS OF THE LDL-RECEPTOR AND LIPOPROTEIN-LIPASE GENES IN FAMILIES OF FAMILIAL COMBINED HYPERLIPIDEMIA, Atherosclerosis (Amsterdam), 138, 1998, pp. 26-26
EFFECT OF MICRONIZED FENOFIBRATE ON PLASMA-LIPOPROTEIN LEVELS AND HEMOSTATIC PARAMETERS IN THE FED AND FASTED STATE
Authors: GENEST J THEROUX P DAVIGNON J COHN JS
Citation: J. Genest et al., EFFECT OF MICRONIZED FENOFIBRATE ON PLASMA-LIPOPROTEIN LEVELS AND HEMOSTATIC PARAMETERS IN THE FED AND FASTED STATE, Circulation, 98(17), 1998, pp. 1237-1237
REMNANT-LIKE PARTICLES ARE ENRICHED IN APOC-III IN PATIENTS WITH FASTING HYPERTRIGLYCERIDEMIA AND FURTHER ENRICHED IN APOC-III IN HYPERTRIGLYCERIDEMIC PATIENTS FED A FAT-RICH MEAL
Authors: MARCOUX C TREMBLAY M FREDENRICH A NAKAJIMA K DAVIGNON J COHN JS
Citation: C. Marcoux et al., REMNANT-LIKE PARTICLES ARE ENRICHED IN APOC-III IN PATIENTS WITH FASTING HYPERTRIGLYCERIDEMIA AND FURTHER ENRICHED IN APOC-III IN HYPERTRIGLYCERIDEMIC PATIENTS FED A FAT-RICH MEAL, Circulation, 98(17), 1998, pp. 2926-2926
CURRENT AND FUTURE TREATMENT OF HYPERLIPIDEMIA - THE ROLE OF STATINS
Authors: FARNIER M DAVIGNON J
Citation: M. Farnier et J. Davignon, CURRENT AND FUTURE TREATMENT OF HYPERLIPIDEMIA - THE ROLE OF STATINS, The American journal of cardiology, 82(4B), 1998, pp. 3-10
CLINICAL EFFICACY AND SAFETY OF CERIVASTATIN - SUMMARY OF PIVOTAL PHASE IIB III STUDIES/
Authors: DAVIGNON J HANEFELD M NAKAYA N HUNNINGHAKE DB INSULL W OSE L
Citation: J. Davignon et al., CLINICAL EFFICACY AND SAFETY OF CERIVASTATIN - SUMMARY OF PIVOTAL PHASE IIB III STUDIES/, The American journal of cardiology, 82(4B), 1998, pp. 32-39
METHODS AND END-POINT ISSUES IN CLINICAL DEVELOPMENT OF LIPID-ACTING AGENTS WITH PLEIOTROPIC EFFECTS
Authors: DAVIGNON J
Citation: J. Davignon, METHODS AND END-POINT ISSUES IN CLINICAL DEVELOPMENT OF LIPID-ACTING AGENTS WITH PLEIOTROPIC EFFECTS, The American journal of cardiology, 81(8A), 1998, pp. 17-23
CONSENSUS FOR THE USE OF FIBRATES IN THE TREATMENT OF DYSLIPOPROTEINEMIA AND CORONARY HEART-DISEASE
Authors: FRUCHART JC BREWER B LEITERSDORF E BROCHIER M BROWN G CALVO C CARMENA R CESKA R LOYSOONG WC DAVIGNON J GOTTO A GRUNDY S HAMSTEN A KEECH A MATSUZAWA Y PATCH JR PAOLETTI R RASLOVA K SMIRNOV V STEINER G THOMPSON G ZHU JR
Citation: Jc. Fruchart et al., CONSENSUS FOR THE USE OF FIBRATES IN THE TREATMENT OF DYSLIPOPROTEINEMIA AND CORONARY HEART-DISEASE, The American journal of cardiology, 81(7), 1998, pp. 912
EFFICACY AND SAFETY OF A NEW HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH COMBINED HYPERLIPIDEMIA -COMPARISON WITH FENOFIBRATE
Authors: OOI TC HEINONEN T ALAUPOVIC P DAVIGNON J LEITER L LUPIEN PJ SNIDERMAN AD TAN MH TREMBLAY G SORISKY A SHURZINSKE L BLACK DM
Citation: Tc. Ooi et al., EFFICACY AND SAFETY OF A NEW HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH COMBINED HYPERLIPIDEMIA -COMPARISON WITH FENOFIBRATE, Arteriosclerosis, thrombosis, and vascular biology, 17(9), 1997, pp. 1793-1799
PREVALENCE OF DOUBLE PRE-BETA LIPOPROTEINEMIA IN HYPERLIPIDEMIC PATIENTS IS INFLUENCED BY GENDER, MENOPAUSAL STATUS, AND APOE PHENOTYPE
Authors: COHN JS GIROUX LM FORTIN LJ DAVIGNON J
Citation: Js. Cohn et al., PREVALENCE OF DOUBLE PRE-BETA LIPOPROTEINEMIA IN HYPERLIPIDEMIC PATIENTS IS INFLUENCED BY GENDER, MENOPAUSAL STATUS, AND APOE PHENOTYPE, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2630-2637
ASSOCIATION OF AN EXON-3 MUTATION (TRP66-]GLY) OF THE LDL RECEPTOR WITH VARIABLE EXPRESSION OF FAMILIAL HYPERCHOLESTEROLEMIA IN A FRENCH-CANADIAN FAMILY
Authors: LEVY E MINNICH A CACAN SL THIBAULT L GIROUX LM DAVIGNON J LAMBERT M
Citation: E. Levy et al., ASSOCIATION OF AN EXON-3 MUTATION (TRP66-]GLY) OF THE LDL RECEPTOR WITH VARIABLE EXPRESSION OF FAMILIAL HYPERCHOLESTEROLEMIA IN A FRENCH-CANADIAN FAMILY, Biochemical and molecular medicine, 60(1), 1997, pp. 59-69
METABOLIC FACTORS CLUSTERING, LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN-B, LIPOPROTEIN (A) AND APOLIPOPROTEIN-E PHENOTYPES IN PREMATURE CORONARY-ARTERY DISEASE IN FRENCH-CANADIANS
Authors: WEBER M MCNICOLL S MARCIL M CONNELLY P LUSSIERCACAN S DAVIGNON J LATOUR Y GENEST J
Citation: M. Weber et al., METABOLIC FACTORS CLUSTERING, LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN-B, LIPOPROTEIN (A) AND APOLIPOPROTEIN-E PHENOTYPES IN PREMATURE CORONARY-ARTERY DISEASE IN FRENCH-CANADIANS, Canadian journal of cardiology, 13(3), 1997, pp. 253-260
METABOLIC AISLE FACTOR CLUSTERING IN PREMATURE CORONARY-ARTERY DISEASE IN FRENCH-CANADIANS
Authors: GENEST J WEBER M MCNICOLL S LUSSIERCACAN S DAVIGNON J LATOUR Y
Citation: J. Genest et al., METABOLIC AISLE FACTOR CLUSTERING IN PREMATURE CORONARY-ARTERY DISEASE IN FRENCH-CANADIANS, Journal of the American College of Cardiology, 29(2), 1997, pp. 7765-7765
CEFIXIM VERSUS AMOXICILLIN-CLAVULANATE IN THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC-BRONCHITIS, IN PATIENTS WITH RISK-FACTORS
Authors: ZUCK P RIO Y TRINH A DELAVAULT P PETITFRERE I CLAUDE JL CROCE C CAUBEL F DOVAN R GROSSIER JM HENLE D KOCH C MULLER D PERREIN C PIERRON J PRIME T RICHTER D ROSZAK E MONIEZ D DOURNOVO P MONTEAU N CAVALIER B ALLEGRINI C GRIMALDI JF GUERIN P GUIRAUD JP PUGET A LEONARDELLI M ALFIERISIADOUS M BERACASSAT C DAVIGNON J GIRARD D PELLETIER M NAUDIN G VINCENT J FERRU J ABITBOL JP AVAKIAN A BENEVISE B CONNAN JB DEVALMONT D SAUTEREAU O HERMAN D LAUBY M BALTUS C GAILLARD JR PLAN P ROLLAND C TAURILPIBRE EL VIDAL M GARCIN L LIEB F LIEBBAZILE C AURIOL P CAUSSE P DADOLLE C PARTRAT Y PRIEUR T VERGNON JM ROS A HANRION P PLANEL P BERAUD A HOUPPERT Y DUPONT B FOUCHARD JL MANTOVANI M SILVAIN C DEBIEUVRE D CHANTELAT P BLANCHON F GRIGNET JP ROYER E AMAR P BENSOUSSAN R BISMUTH D BRILLAUX F DORFMANN M DUCLOS G FONTAINE M GARCON G GIRARD P GUTH PC KICHELEWSKI S LEVY D NEDELEC P VASSEUR G WALTER P BEAUCE A TRAN VT LABESCAT J COMPAN D SCHEIMBERG A MOURET G DEPEUFEILHOUX A MENZEL R
Citation: P. Zuck et al., CEFIXIM VERSUS AMOXICILLIN-CLAVULANATE IN THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC-BRONCHITIS, IN PATIENTS WITH RISK-FACTORS, Medecine et maladies infectieuses, 27(5), 1997, pp. 603-610
THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS
Authors: CAMPEAU L KNATTERUD GLMK DOMANSKI M HUNNINGHAKE DB WHITE CW GELLER NL ROSENBERG Y HERD A COCANOUGHER MK DUNN K FARMER J FOREYT J GREGORY K INSULL W JACKSON M KLEIMAN N LEWIS R LLOYD C MARESH K MATTHEW C MINOR S ROBERTS R SALMON A SHACKELFORD P STEWART R THOMPSON M YOUNG J GUINN A HARRIS G HEIBIG J LEVY VV FORRESTER J HICKEY A BUCHBINDER N DAVIDSON R DRURY K EBER L EIGLER N GEFT I GOLDBERG S GRODAN P HENDEL J HIGGINS S HODGSON T HUGHES L KARLSBERG R KATZ J LEPOR N LITVAK F LUPTAK Y MADERA G MARCUS H MONDKAR A NEIDORF B NEUMANN M NIVATPUMIN T RABINOWITZ Y RAYMOND M READER A RURYCZ V SCHAPIRA J SCHLANGER J SILVERBERG R SMITH A TABAK S VALOVIS R GRAY R HOOGWERF B STEWART W BAERVEDT G BOTTSILVERMAN C BREEN C BUCKNER P CABRAL J CRESSMAN M FONSECA C FOSTER J FOSTER R GUTMAN F HARRIS L HEUPLER F HOBBS R HUANG S KALENAK J KASSEM M KOSMORSKY G KRAMER J KURZAWA C LANGSTON R LINCOFF M LINDBERG J LOWDER C MCCAFFERTY F MCKEOWN D MEISLER D MENDLOVIC D MEYERS S MOORE J NOUSEK J RAYMOND R RINCON G ROBIN J ROCKWOOD E SHELDON W SIMPFENDORFER C WALSH H WANESS A WRIGHT K YANAK F GOULET C BEDARD H BOIS M BUJOLD S COTE G DAVIGNON J DEBELDER M DUCHARME AM DOUCET S DUMAS J DYDRA I FOUCHER S CREPEAU J GOSSELIN G GROULX D JOYAL M JUNEAU M LESPERANCE J LEVESQUE C LEVESQUE J MARCIL M OLIVIER M PASTERNAC A POITRAS AM POITRAS D QUEVILLON A RIOUX C ROBITAILLE D SISOUPHONE K SOLYMOSS C HUNNINGHAKE D CHRISTIANSON B DIANGELIS N GARDNER K HELGREN R IACARELLA C KNOBLOCH W LAU L LAXSON D LEON A LONDON E MANION R MCDONALD K MCGINN A MIANULLI M ROBINSON J TURNER G WANG Y WHITE C WILSON R ZIMMER S GOBEL F ANDERSON P BAUMGARD C CHRISTENSEN J FULCO A HANSON K JOHNSON C LARSON B MADISON J MCCORMACK P OSTROV C PECHA R PEDERSON W PIER T RANDALL M RODMAN W ROELLER S SCOTT K SHER N SPEILMAN J THOMPSON R ZUPFER S GOLDENBERG I HEALY B KNATTERUD G TERRIN M CANNER M FICK S FORMAN S HANSON D HOWARD J HUANG AL KARABELAS S LOPRESTI F MERCER W RA K RANDALL A SCHACTMAN M SCHLEIGH B SNIDER R MIRENZI E FISHER M FOX NL CZAJKOWSKI S GELLER N PROBSTFIELD J SHUMAKER S WITTES J YUSUF S ZUCKER D CARTLAND J DAS G MEYER S POWERS T RINGDAL D ROSZA Z SHAHEEN B SIREK M STONE C SNIDER J VANYI J ALAUPOVIC P FESMIRE J WALENGA J BERMES E HOPPENSTEADT D PIFARRE R CARLETON R BAILEY K BRODY B CAIRNS J FURBERG C FUSTER V GRONDIN C JENKINS D LAROSA J MEIER P
Citation: L. Campeau et al., THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS, The New England journal of medicine, 336(3), 1997, pp. 153-162
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>